Guidelines for supportive care in multiple myeloma 2011
John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Jennifer M. Bird(University Hospitals Bristol NHS Foundation Trust), Timothy J. Littlewood(John Radcliffe Hospital), Sam H. Ahmedzai(University of Sheffield), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Eric Low(Myeloma UK), John Ashcroft(Leeds Teaching Hospitals NHS Trust), Rhona Maclean(Royal Hallamshire Hospital), Shirley D’Sa(University College Hospital), H.H. Lucraft(Freeman Hospital), Sylvia Feyler(Calderdale and Huddersfield NHS Foundation Trust)
Cited by 209
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
|European Journal of Cancer|1994|878
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
|The Lancet|2010|571
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma
|British Journal of Haematology|2004|447